Itamar Medical Ltd is a medical technology company focused on the development, marketing and sales of diagnostic products based on its proprietary PAT® platform technology, developed by a team of leading clinicians in sleep medicine and cardiology together with biomedical engineers and physicists.
Our proprietary technology enables the non-invasive recording, measurement and analysis of Peripheral Arterial Tonometry, or the PAT® signal. The PAT® signal measures changes in a patient’s pulsatile arterial volume, providing a “window” to the cardiovascular system and the sympathetic branch of the autonomic nervous system.
Non-invasive assessment of endothelial function
Click here for a step-by-step instructional video on how to use the WatchPAT™
EndoPAT helps predict dengue fever
June 21, 2015
EndoPAT distributor in China - Important Notice
April 26, 2015
Itamar Medical Launches WatchPAT™ Unified
June 09, 2014
Itamar Medical's EndoPAT™ Featured on the Doctor's Channel
March 02, 2014
ESC - European Society of Cardiology
August 29, 2015
AHA - American Heart Association
November 08, 2015
ACC - American College of Cardiology 2016
April 02, 2016
HRS- Heart Rhythm Society Meeting
May 04, 2016
ATS- American Thoracic Society
May 13, 2016